Why Is TScan Therapeutics Stock Gaining Today?

TScan Therapeutics’ stock rises after announcing a $30 million financing deal with Lynx1, extending its cash runway into 2027.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *